TRI-CON 2024 Poster Presentations Coming in February




2023 Poster Presentations

P01: Machine Learning Algorithms Developed Using Large Real-World Dataset Can Appreciably Improve Multi-Cancer Early Detection with Protein Tumor Biomarkers, Presented by Jiming Z., 20/20 GeneSystems, Inc.

P02: Molecular Mechanisms of Oxytocin-Induced Contraction in Rat Gastric Smooth Muscle- Oxytocin a Novel Prokinetic Hormone, Presented by Mohammad A., Arabian Gulf University

P03: Enzyme Evolution: Next Generation Technology, Presented by Gbemisola F., Asymchem, Inc.

P04: Network Enhanced Similarity Search Increases the Predictive Power of a Highly Heterogenous Network, Presented by Everest C., Baylor University

P05: The OptiDrop Microfluidic Analyser: Multiplexed Fluorescence and Scatter Detection with Single Cell Resolution Using On-Chip Fibre Optics for Droplet Microfluidic Applications, Presented by Preksha G., Centre for Cellular and Molecular Platforms (C-CAMP)

P06: Application of a Digital PCR Platform to Oncology Studies, Presented by Leah RH., ChromaCode, Inc.

P07: Centinela Diagnostics: Laboratory Science at the Point of Care, Presented by William P., Ciencia, Inc.

P08: Evaluation and Limitations of Different Approaches Among COVID-19 Fatal Cases Using Whole-Exome Sequencing Data, Presented by Natalia F., Comenius University

P09: Computational Method for the Detection of Microsatellite Instability in Tumor Tissue Samples, Presented by Werner K., Comenius University

P10: Cell-Free Nucleic Acid-Based Copy Number Variation Analysis in Plasma of Colorectal Cancer Patients, Presented by Ondrej P., Comenius University

P11: Monitoring the Circulating SARS-CoV-2 Through Wastewater Surveillance at National Scale in the Slovak Republic, Presented by Peter R., Comenius University

P12: Distribution of Polygenic Risk Scores in Families with Inflammatory Bowel Disease, Presented by Jan R., Comenius University

P13: Repurposing of Whole-Genome Sequencing Data from Lynch Syndrome-Associated Colorectal Tumors: Detection of Somatic MSI Events, Presented by Jakub S., Comenius University

P14: Integrating National SARS-CoV-2 Genomic Surveillance Efforts in Slovakia on Illumina Sequencing Platforms for Public Health Management, Presented by Tomas S., Comenius University

P15: Viability of Urinary MicroRNA in Cancer Early Detection, Presented by Kristine M., Craif, Inc.

P16: The Circulating Tumor Cells Can Monitor the Effectiveness of Papillary Thyroid Cancer-Removal Surgery, Presented by Eunju P., CytoDx

P17: A Fast Sub-Hour Accurate Point-of-Care Detection of SARS-CoV-2 Variants by XNA-Based RT-qPCR, Presented by Andrew F., DiaCarta, Inc.

P18: Cost-Effective cfDNA Extraction Kits for Liquid Biopsy Studies and Tests, Presented by Wei L., DiaCarta, Inc.

P19: High-Throughput and Highly Sensitive Mpox Test with QuantiVirus™ MPXV Test Kit, Presented by Shuo S., DiaCarta, Inc.

P20: TARDES™: A CRISPR/Cas9 Target gRNA and Primer Design Tool for Detecting Cancer Variants, Presented by YoonHoo L., GeneCker Co., Ltd.

P21: A Patient-Administered Digital Tool Is Efficient, Usable, and Effective at Identifying Patients with Hereditary Cancer Risk, Enabling Prevention and Early Detection of Cancer, Presented by Colleen C., Genome Medical, Inc.

P22: Isolation of Circulating Tumor Cells with a New Medical Device: The BMProbe, Presented by Jasmin P., HaimaChek

P24: HBDx Engine - A Platform for Ultra-Deep Detection and Validation of Small RNAs from Liquid Biopsies, Presented by Rastislav H., Hummingbird Diagnostics GmbH

P25: Illumina Complete Long Read Assay with Probe Hybridization-Based Target Enrichment, Presented by Feng C., Illumina, Inc.

P26: Low-Depth Native-Molecule Whole-Genome Nanopore-Sequencing of Lung Cancer Cell-Free DNA Samples with EGFR and TP53 Co-Mutations, Presented by Vincent F., Imagia Canexia Health

P27: Depicting the Cellular Architecture of the Tumor Microenvironment by Integrating Hyperplex Immunofluorescence and Automated Image Analysis, Presented by Jeff D., Indica Labs

P28: A Universal Day Zero Infectious Disease Testing Strategy Leveraging CRISPR-Based Sample Depletion and Metagenomic Sequencing, Presented by Keith B., Jumpcode Genomics, Inc.

P29: Agnostic Diagnostic: CRISPR Based Host Depletion for Improved Metagenomic NGS, Presented by Keith B., Jumpcode Genomics, Inc.

P30: A Validated Serum α2,6-sialylated Glycoform of Serotransferrin as a Novel Glycoprotein Biomarker for the Diagnosis of Cholangiocarcinoma, Presented by Phongsaran K., Khon Kaen University

P31: Integrative Analysis of Transcriptomic and Epigenomic Dynamics of Liver Organoids Using Single Cell RNA-seq and ATAC-seq, Presented by Jong Hwan K., Korea Research Institute of Bioscience and Biotechnology (KRIBB)

P32: Overview of the Data Processing Pipeline for the Korea Bio Big Data, Presented by Sangok K., Korea Research Institute of Bioscience and Biotechnology (KRIBB)

P33: Metastatic Ability of Lung Cancer Stromal Cells from a Single Cell RNA-seq Perspective, Presented by Joy Y., Korea Research Institute of Bioscience and Biotechnology (KRIBB)

P34: CRISPincette, an Effective Liquid Biopsy System Using GeneCker-Cas9, Presented by Taegun P., Korea University

P35: Role of Gut Microbiome Analysis in High-Definition Medicine-Based Personalized Health Preservation, Presented by Richard K., Medipredict Health

P36: Accelerated Pathogen Detection from Urine Samples Using Inhibitor-Tolerant qPCR and LAMP Master Mixes, Presented by Michele A., Meridian Life Science

P37: Sensitive and Accurate Detection of SNPs and Differential DNA Methylation Using Specimen-Specific™ qPCR Mixes, Presented by Evelyn T., Meridian Life Science

P38: Development of Reference Material for Methylated cfDNA Measurement, Presented by Zhiyong H., National Institute of Standards and Technology

P39: The Basics of NIH Small Business Grant Peer Review, Presented by John L., National Institutes of Health, Center for Scientific Review

P40: Liquid Biopsy for Predicting Immunotherapy Response, Presented by Andrew S., National Institutes of Health, National Cancer Institute

P41: RADx-rad Initiatives: COVID-19 Testing and Surveillance Through Exosome-Based and Breath-Based Technologies, Presented by Chariz J., National Institutes of Health, National Center for Advancing Translational Sciences

P42: Raman Spectroscopy and Machine Learning for Rapid Identification and Determination of Viral Nearest Neighbors, Presented by RyeAnne R., National Institutes of Health, National Institute of Allergy and Infectious Diseases

P43: Detection of Somatic Variants in Breast Cancer from Large Volumes of Plasma Using nRichDX Revolution System™, Presented by Mayer S., nRichDX

P44: Okomera: Functional Precision Medicine Enabled by Droplet Microfluidics, Presented by Layla F., Okomera

P45: Combinatorial Drug Screening on 3D Ewing Sarcoma Spheroids Using Droplet-Based Microfluidics, Presented by Gaetan M., Okomera

P46: Next-Generation Metabolomics for Pathway Analysis in Serum and Liver of ApoE Knockout Rats, Presented by Ethan S., Panome Bio

P47: Targeted Transcriptome Sequencing Enables Exponential Scaling of Combinatorial Barcoding, Presented by Serena C., Parse Biosciences

P48: A Novel, Highly Sensitive Approach Using Digital PCR for Residual Disease Detection in AML, Presented by Duy N., Quest Diagnostics Nichols Institute

P49: Less Invasive SARS-CoV-2 Testing for Children: A Comparison of Saliva and a Novel Anterior Nasal Swab, Presented by Marnie C., Rhinomed Ltd.

P50: Digital Pathology Solutions for Validation of Oncology Immunohistochemistry Assays, Presented by Nathaniel H., Roche Tissue Diagnostics

P51: Automated Detection of KRAS Amplification and Heterogeneity from Whole Slide Images, Presented by Skyler S., Roche Tissue Diagnostics

P52: A Scalable Micro-Fluidic Chip Adapting Large Number of Micro-Channels for Mass Production of Liposome, Presented by Yeong-Eun Y., Korea Institute of Machinery and Materials

P53: Characterization of Circulating Tumor Cells using GenoCTC® from Breast Cancer Patients Reveals Their Relevance in Prognosis and Recurrence Prediction, Presented by Ryan L., Seoul National University

P54: Challenges of Characterization of Medically Relevant Short Tandem Repeats from Whole-Exome and Whole-Genome Sequencing Data, Presented by Ingrid L., Slovak Academy of Sciences

P55: Method Comparison of Commercially-Available cfDNA Extraction Products for Minimum Residual Disease Next Generation Sequencing, Presented by Travis R., Strata Oncology

P56: Be Nice to Your Cells! Gentle Cell Handling with Microfluidics for Better Results, Presented by Magdalena S., STRATEC Consumables GmbH

P57: Virus Detection and Identification in Minutes Using Single-Particle Imaging and Deep Learning, Presented by Alex B., University of Oxford/Pictura Bio Ltd.

P58: Liquid Gold - The Promise of Aqueous Humor, Presented by Liya X., University of Southern California

P59: Significant Inconsistences Among the Technical Approaches Applied for Gut Microbiome Analyses, Presented by Dora T., University of Szeged

P60: Detection of Early Stage Hepatocellular Carcinoma Using Plasma Methylated DNA, Presented by Si-Cho K., Yonsei University

P61: Development of a Molecular Blood Test for Colorectal Cancer Screening Using Expression Profiles of Tumor-Associated Circulating Transcripts, Presented by Hyeyoung L., Yonsei University

P62: New Advanced Sensing Technology Using a Graphene Biosensor, Presented by Eric R., Forever North Partners LLC

P63: Hotspot DNA Mutations in Saliva as a Diagnostic Marker in Patients with Oral Squamous Cell CarcinomaPresented by Harald L., Hanse Genetik

P64: Evaluation of a Ubiquitous Blood Test for the Early Detection of Patients with Increased Cancer Risk in the Context of Health ScreeningsPresented by Harald L., Hanse Genetik

V1: Optimization of MET Exon 14 Skipping Testing for Lung Cancer Patients, Presented by Shih-Cheng C., Chang Gung Memorial Hospital

V2: Specific Capture of Nucleic Acid on Dynabeads™ for Target Enrichment from Liquid Biopsies, Presented by Laure J., Thermo Fisher Scientific

V3: Enabling Generation of High Quality NGS Libraries with Bead-Based Target Enrichment for Enhanced NGS Readouts, Presented by Hannah L., Thermo Fisher Scientific



Register Now
March 26-27, 2024

AI in Precision Medicine

Implementing Precision Medicine

At-Home & Point-of-Care Diagnostics

Liquid Biopsy

Spatial Biology

March 27-28, 2024

AI in Diagnostics

Diagnostics Market Access

Infectious Disease Diagnostics

Multi-Cancer Early Detection

Single-Cell Multiomics